Artesunate for Injection
/ Amivas
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
February 28, 2025
Study Evaluating the Efficacy and Safety of Artesunate
(clinicaltrials.gov)
- P2 | N=90 | Not yet recruiting | Sponsor: Amivas (US), LLC
New P2 trial • Cytomegalovirus Infection • Infectious Disease • Solid Organ Transplantation • Transplantation
December 10, 2024
Evaluation of Artesunate in Infants Being Treated for Severe Malaria
(clinicaltrials.gov)
- P=N/A | N=15 | Recruiting | Sponsor: Amivas (US), LLC | Not yet recruiting ➔ Recruiting
Enrollment open • Infectious Disease • Malaria
August 15, 2024
Evaluation of Artesunate in Infants Being Treated for Severe Malaria
(clinicaltrials.gov)
- P=N/A | N=15 | Not yet recruiting | Sponsor: Amivas (US), LLC
New trial • Infectious Disease • Malaria
1 to 3
Of
3
Go to page
1